Pfizer Close to Purchase of German Generics Firm

Just a few months after closing its $67 billion acquisition of Wyeth Pharmaceuticals, Pfizer Inc. stands ready to spend another $4 billion or so for Germany’s leading maker of generic medications.
The Day